肾根治性切除联合静脉瘤栓取出术后并发症预测:简化风险计算器
该研究基于2000至2021年617例因肾细胞癌行肾切除术联合静脉瘤栓取出术的患者,开发预测术后30天内高级别并发症的列线图。高级别并发症发生率为9.2%,且随瘤栓头侧延伸程度升高:肾静脉仅4.7%、下腔静脉11.6%、膈上30.8%(P<.001)。瘤栓水平、同期手术和ECOG体能状态是主要预测变量,下腔静脉重建技术无显著影响。
要点
- 高级别并发症率随瘤栓水平升高:肾静脉4.7%、下腔静脉11.6%、膈上30.8%。
- 下腔静脉重建技术(直接缝合、补片、管状移植物、结扎)不改变并发症率。
- 基于瘤栓水平、同期手术和ECOG状态的列线图可辅助患者选择和术前咨询。
核心结论
- 瘤栓水平、预期同期手术和患者体能状态与术后30天内高级别并发症相关,而下腔静脉重建技术无关。
- 内部验证的简约列线图可能有助于手术患者选择和个体化术前咨询。
研究设计与样本
- 回顾性评估2000至2021年因肾细胞癌行肾切除术和静脉瘤栓取出术的患者617例。
- 主要结局为术后30天内发生高级别并发症;采用LASSO逻辑回归筛选预测变量并构建列线图。
主要发现
- 617例患者中高级别并发症发生率为9.2%,且随瘤栓头侧延伸程度增加:肾静脉仅4.7%、下腔静脉11.6%、膈上30.8%(P<.001)。
- 30天死亡率为<1%。
- 在瘤栓延伸至下腔静脉或更高的患者中,直接缝合、补片静脉成形、管状移植物置换或下腔静脉结扎的高级别并发症率无差异。
- 预测高级别并发症判别能力最高的变量为:瘤栓水平、同期手术和ECOG体能状态。
- 列线图在开发队列(70%)中AUC=0.69,在验证队列(30%)中AUC=0.77。
临床怎么用
- 可利用瘤栓水平、同期手术和ECOG体能状态评估术后30天内高级别并发症风险。
- 下腔静脉重建技术的选择可能不基于并发症风险差异。
- 列线图可辅助患者选择和个体化术前咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop an individualized risk calculator for major complications after radical nephrectomy and tumor thrombectomy performed for renal cell carcinoma (RCC). METHODS: We assessed patients who underwent nephrectomy and venous tumor thrombectomy for RCC from 2000 to 2021. The primary outcome was experiencing a high-grade complication within 30 days of surgery. A LASSO logistic regression model screened variables to identify predictors of major complications, which were subsequently used to create a nomogram. RESULTS: Among 617 patients, high-grade complications occurred in 9.2% of patients and increased with the increasing cephalad extent of VTT: 4.7% (renal vein only), 11.6% (IVC), and 30.8% (supradiaphragmatic), P <.001. The 30-day mortality rate was <1%. In patients with thrombus extending into the IVC or higher, there was no difference in high-grade complication rates with primary closure, patch venoplasty, tube graft replacement, or IVC ligation. The variables with the highest discriminative ability to predict major complications were: thrombus level, concurrent surgery, and ECOG performance status. These variables were used to develop a nomogram that had an AUC = 0.69 in the development cohort (70%) and AUC = 0.77 in the validation cohort (30%). CONCLUSION: Thrombus level, anticipated concurrent surgery, and patient performance status, though not IVC reconstruction technique, were associated with major complications in the first 30 days after surgery. Our internally validated, parsimonious nomogram predicting major complications after nephrectomy for RCC with VTT may aid surgeons in patient selection and individualize preoperative counseling.
引用
- Roberson DS, Basourakos SP, Dorr M, et al. Predicting Complications After Radical Nephrectomy With Venous Tumor Thrombectomy and Various IVC Reconstruction Approaches: A Simplified Risk Calculator. Urology. 2026. PMID: 42435775. doi:10.1016/j.urology.2026.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。